Mutant TDP-43 deregulates AMPK activation by PP2A in ALS models.

Mutant TDP-43 deregulates AMPK activation by PP2A in ALS models.

Show other versions (1)

Bioenergetic abnormalities and metabolic dysfunctionoccur in amyotrophic lateral sclerosis (ALS) patients and genetic mouse models. However, whether metabolic dysfunction occurs earlyin ALS pathophysiology linked to different ALS genes remains unclear.Here, we investigatedAMP-activated protein kinas...

Full description

Bibliographic Details
Main Authors:	Nirma D Perera, Rebecca K Sheean, John W Scott, Bruce E Kemp, Malcolm K Horne, Bradley J Turner
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3942426?pdf=render

Similar Items

Mutant TDP-43 deregulates AMPK activation by PP2A in ALS models.
by: Nirma D Perera, et al.
Published: (2014-01-01)

ALS-associated TDP-43 induces endoplasmic reticulum stress, which drives cytoplasmic TDP-43 accumulation and stress granule formation.
by: Adam K Walker, et al.
Published: (2013-01-01)

Explore the role of AMPK activation in TDP-43 mislocalization and cell death
by: Li-Ming Lee, et al.
Published: (2014)

Divergent phenotypes in mutant TDP-43 transgenic mice highlight potential confounds in TDP-43 transgenic modeling.
by: Simon D'Alton, et al.
Published: (2014-01-01)

Stimulation of mTOR-independent autophagy and mitophagy by rilmenidine exacerbates the phenotype of transgenic TDP-43 mice
by: Nirma D. Perera, et al.
Published: (2021-07-01)

Progranulin reduces insoluble TDP-43 levels, slows down axonal degeneration and prolongs survival in mutant TDP-43 mice
by: Sander Beel, et al.
Published: (2018-10-01)

Age-dependent neurodegeneration and organelle transport deficiencies in mutant TDP43 patient-derived neurons are independent of TDP43 aggregation
by: N. Kreiter, et al.
Published: (2018-07-01)

TDP-43 and Limbic-Predominant Age-Related TDP-43 Encephalopathy
by: Lumi Zhang, et al.
Published: (2020-01-01)

DCTN1 Binds to TDP-43 and Regulates TDP-43 Aggregation
by: Manami Deshimaru, et al.
Published: (2021-04-01)

ALS-linked TDP-43M337V knock-in mice exhibit splicing deregulation without neurodegeneration
by: Seiji Watanabe, et al.
Published: (2020-01-01)

Mutant TDP-43 does not impair mitochondrial bioenergetics in vitro and in vivo
by: Hibiki Kawamata, et al.
Published: (2017-05-01)

Expression of mutant TDP-43 induces neuronal dysfunction in transgenic mice
by: Dickson Dennis W, et al.
Published: (2011-10-01)

Chaperone Mediated Autophagy Degrades TDP-43 Protein and Is Affected by TDP-43 Aggregation
by: Fernando Ormeño, et al.
Published: (2020-02-01)

Mice Carrying ALS Mutant TDP-43, but Not Mutant FUS, Display In Vivo Defects in Axonal Transport of Signaling Endosomes
by: James N. Sleigh, et al.
Published: (2020-03-01)

TDP-43: From Alzheimer’s Disease to Limbic-Predominant Age-Related TDP-43 Encephalopathy
by: Wendi Huang, et al.
Published: (2020-02-01)

TDP-43 mislocalization drives neurofilament changes in a novel model of TDP-43 proteinopathy
by: Rachel Atkinson, et al.
Published: (2021-02-01)

Prion-like mechanisms of TDP-43 in ALS
by: Smethurst, P.
Published: (2014)

The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD
by: Britt A. Berning, et al.
Published: (2019-04-01)

Spreading of TDP-43 pathology via pyramidal tract induces ALS-like phenotypes in TDP-43 transgenic mice
by: Xuebing Ding, et al.
Published: (2021-01-01)

Mutant TDP-43 and FUS cause age-dependent paralysis and neurodegeneration in C. elegans.
by: Alexandra Vaccaro, et al.
Published: (2012-01-01)

Progranulin is neurotrophic in vivo and protects against a mutant TDP-43 induced axonopathy.
by: Angela S Laird, et al.
Published: (2010-01-01)

The pathological phenotypes of human TDP-43 transgenic mouse models are independent of downregulation of mouse Tdp-43.
by: Ya-Fei Xu, et al.
Published: (2013-01-01)

TDP-43 and Phosphorylated TDP-43 Levels in Paired Plasma and CSF Samples in Amyotrophic Lateral Sclerosis
by: Yuting Ren, et al.
Published: (2021-06-01)

Age-related deregulation of TDP-43 after stroke enhances NF-κB-mediated inflammation and neuronal damage
by: Sai Sampath Thammisetty, et al.
Published: (2018-11-01)

Mechanisms and models of TDP-43 proteinopathies
by: Petrucelli Leonard
Published: (2012-02-01)

Molecular Neuropathology of TDP-43 Proteinopathies
by: Manuela Neumann
Published: (2009-01-01)

Studies of VAPB and TDP-43 in neurodegeneration
by: Müller, Sarah
Published: (2015)

Characterize the biophysical and chemical properties of TDP-43 in ALS
by: Chu-ya Wu, et al.
Published: (2011)

In vitro prion-like behaviour of TDP-43 in ALS
by: Phillip Smethurst, et al.
Published: (2016-12-01)

Oxidative stress induced by glutathione depletion reproduces pathological modifications of TDP-43 linked to TDP-43 proteinopathies
by: Yohei Iguchi, et al.
Published: (2012-03-01)

Suppression of Conditional TDP-43 Transgene Expression Differentially Affects Early Cognitive and Social Phenotypes in TDP-43 Mice
by: Pablo R. Silva, et al.
Published: (2019-04-01)

A Novel Supplement Attenuates Oxidative Stress-Induced TDP-43-Related Pathogenesis in TDP-43-Expressed Cells
by: Eun Jin Yang
Published: (2021-01-01)

A robust TDP-43 knock-in mouse model of ALS
by: Shih-Ling Huang, et al.
Published: (2020-01-01)

Structural and biochemical properties of the ALS-linked mutations in TDP-43
by: Chiang, Chien Hao, et al.
Published: (2016)

Endocytosis regulates TDP-43 toxicity and turnover
by: Guangbo Liu, et al.
Published: (2017-12-01)

TDP-43 overexpression impairs presynaptic integrity
by: Lanier Heyburn, et al.
Published: (2016-01-01)

Inflammation Induces TDP-43 Mislocalization and Aggregation.
by: Ana Sofia Correia, et al.
Published: (2015-01-01)

TDP-43 domain structure and aggregation studies
by: 王宜婷
Published: (2011)

Study of the Role of TDP-43 in Chromatin Organization
by: Hung-Pei Li, et al.
Published: (2013)

Endocytosis regulates TDP-43 toxicity and turnover
by: Liu, Guangbo, et al.
Published: (2017)